Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.
Owing to the significant breast cancer risk associated with BRCA1 or BRCA2 mutations, women with these mutations have several options available to them by which to reduce the risk of breast cancer. These include surgical (prophylactic mastectomy and prophylactic oophorectomy) and medical (chemoprevention) options. The breast cancer risk reductions associated with these options range from a 90% risk reduction associated with prophylactic mastectomy to approximately 50% with oophorectomy or tamoxifen. This article reviews the efficacy of prophylactic oophorectomy for the prevention of breast cancer in BRCA1 and BRCA2 mutation carriers. The predictors of uptake of the preventive surgery will be discussed, in addition to the psychosocial implications of the surgery.
Metcalfe
Kelly A
KA
Lawrence S Bloomberg, Faculty of Nursing, University of Toronto, 155 College St, Toronto, Ontario, M5T 1P8, Canada. kelly.metcalfe@utoronto.ca
D000328:Adult; D000367:Age Factors; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008594:Menopause, Premature / Q000523:psychology; D008875:Middle Aged; D010052:Ovariectomy / Q000523:psychology; D012307:Risk Factors